News 07.21.20

Berkeley Lights Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

News 07.16.20

Berkeley Lights Announces Pricing of Initial Public Offering

News 07.02.20

Greg Lucier Joins Berkeley Lights’ Board of Directors

News 06.24.20

Berkeley Lights Announces Opto™ Antigen-Presenting Bead Kit to Accelerate the Expansion of Antigen-Specific T Cells Used to Develop Cell-Based Therapies

News 04.27.20

Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies

News 03.31.20

Berkeley Lights Expands Its Platform and Introduces the OptoSeq™ 3' mRNA Library Kit

News 03.25.20

Berkeley Lights Announces the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) to Attack COVID-19 and Other Viruses

News 03.09.20

Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody Therapeutics

News 03.05.20

Berkeley Lights Launches T Cell Receptor Sequencing Kit to Increase Efficiency of T Cell Receptor Discovery

News 02.28.20

Researchers Worldwide Are Using Berkeley Lights' Beacon Platform To Combat COVID-19